Epigenetics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Epigenetics Market is segmented by Product (Instruments, Kits & Reagents, Others), Application, Technology, and Geography.

Market Snapshot

Epigenetics Market-1
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 19.1 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The epigenetics market is expected to register a CAGR of nearly 19.1% during the forecast period. Cancer rates may further increase by 50%, to 15 million new cases, by 2020, as per the World Cancer Report. It also provides clear evidence that healthy lifestyle choices and actions for improving public health, by governments and health practitioners, can prevent as many as one-third of cancer cases, worldwide.

According to the World health Organization, in 2018, around 1.8 million new cases were diagnosed with cancer worldwide. According to the WHO, almost 70% of deaths from cancer occur in low- and middle-income countries, and only one in five low- and middle-income countries has the necessary data to drive cancer-related policies. This worldwide and extensive threat of cancer remains a major driver for the development of new cancer therapies that help in risk assessment, early diagnosis, and effective monitoring of the treatment.

Resistance of cancers to the treatment is a major obstacle. However, epigenetic drugs, on their own or in combination with other drugs, can be a viable alternative. The epigenetic drug used in laboratory study stops the ability of cancer cells to hide from the immune system and makes the tumor vulnerable. Hence, the increasing prevalence of cancer is expected to augment the growth of the epigenetics market.

Scope of the Report

As per the scope of this report, epigenetics, in simple terms, refers to the study of genetic effects that are not entirely encoded by the DNA sequence of an organism. Epigenetics mainly deals with gene expression. Epigenetics also refers to changes in the genome, in terms of functionality, which do not involve the change in the nucleotide sequence. The DNA methylation or histone modification is a type of mechanism that causes epigenetic changes.

By Product
Reagents & Kits
By Application
Autoimmune Diseases
Metabolic Diseases
CNS/Pain Diseases
Cardiovascular Diseases
By Technology
Other Technologies
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle East & Africa
South Africa
Rest of Middle East & Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

By Technology, DNA Methylation is Expected to Hold the Largest Share over the Forecast Period

DNA methylation dominated the epigenetics market, as it is the covalent addition of a methyl group in cytosine ring, which leads to the inhibition of transcription. Sensitive bisulfite modification, followed by PCR, is called methylation sensitive PCR (MSP). Real-time PCR for methylation detection, methyl light, and quantitative analysis of methylated alleles are variations of MSP. Currently, quantitative methods, such as allele-specific bisulphite sequencing, southern-based method, bisulphite pyrosequencing, and bisulphite PCR followed by MALDI - TOF MS, are also useful for DNA methylation. Advancements in technologies are increasingly enabling the assessment of locus-specific DNA methylation on a genome-wide scale.

Epigenetic Market Trend.png

North America Holds the Largest Share of the Epigenetics Market

North America dominates the epigenetics market, owing to the rapid developments in healthcare infrastructure, the presence of major players in the region, and huge investments made in the R&D. With increasing investments being made in the R&D of products by industries, an increase in the demand for protein expression systems is expected, as many mammalian proteins, such as growth hormone, insulin, antibodies, and vaccines, are produced industrially. In the recent years, biopharmaceutical sales have reached 30% of all new pharmaceutical sales in the country. The United States accounts for the world’s largest expenditure on healthcare research. All these factors are expected to augment the growth of the market.

Epigenetic Market - Growth Rate by Region

Competitive Landscape

Competition in the market is set to intensify, as several key players are focusing on the expansion of their epigenetics portfolio, through acquisitions of, and collaborations with other companies. The epigenetics market is expected to open up several opportunities for the new entrants and the currently established leading players.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence and Prevalence of Cancer

      2. 4.2.2 Increasing Funding for R&D in Healthcare

      3. 4.2.3 Rising Epigenetic Applications in Non-oncology Diseases

    3. 4.3 Market Restraints

      1. 4.3.1 Rising Costs of Instruments

      2. 4.3.2 Dearth of Skilled Researchers

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product

      1. 5.1.1 Instruments

      2. 5.1.2 Reagents & Kits

      3. 5.1.3 Others

    2. 5.2 By Application

      1. 5.2.1 Oncology

      2. 5.2.2 Autoimmune Diseases

      3. 5.2.3 Metabolic Diseases

      4. 5.2.4 CNS/Pain Diseases

      5. 5.2.5 Cardiovascular Diseases

      6. 5.2.6 Others

    3. 5.3 By Technology

      1. 5.3.1 Methylation

      2. 5.3.2 Acetylation

      3. 5.3.3 Phosphorylation

      4. 5.3.4 Other Technologies

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East & Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Abcam PLC

      2. 6.1.2 Active Motiff

      3. 6.1.3 Diagenode Inc.

      4. 6.1.4 F. Hoffmann-La Roche Ltd

      5. 6.1.5 Illumina Inc.

      6. 6.1.6 Merck & Co. Inc.

      7. 6.1.7 Qiagen NV

      8. 6.1.8 Thermo Fisher Scientific

      9. 6.1.9 Zymo Research Corporation

    2. *List Not Exhaustive

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Epigenetics Market market is studied from 2018 - 2026.

The Epigenetics Market is growing at a CAGR of 19.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abcam PLC, Active Motiff, Illumina Inc., Merck & Co., Diagenode Inc. are the major companies operating in Epigenetics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!